中东和非洲血糖监测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

中东和非洲血糖监测市场按产品类型(自我监测血糖、连续血糖监测)和地理划分。

市场快照

Middle-East and Africa Blood Glucose Monitoring Market Overview
Study Period: 2016-2027
Base Year: 2021
CAGR: >11 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期间(2021 - 2026 年),中东和非洲血糖监测市场的复合年增长率预计将超过 11%。到 2021 年,该市场预计将达到 3.4 亿美元以上。在发展中国家,糖尿病等生活方式疾病的发病率不断增加,这正在增加对血糖监测设备的需求。对医疗保健设施和预防保健的认识提高也支持市场的增长。依赖自我监测血糖(SMBG)的患者数量有所增加。由于与连续血糖监测 (CGM) 相关的高成本限制,通过血糖仪进行自我监测在中东和非洲地区更容易接受。这些设备有助于及早发现低血糖和高血糖状况,

报告范围

该研究对自我监测血糖装置和连续血糖监测装置进行了详细分析。设备进一步按组件分类,即自我监测血糖(SMBG)设备分为血糖仪设备、试纸和柳叶刀,连续血糖监测(CGM)设备分为传感器和耐用品,并进一步分为中东和非洲地区国家。

Self-monitoring Blood Glucose
By Component (Value and Volume, 2016 - 2026)
Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring
By Component (Value and Volume, 2016 - 2026)
Sensors
Durables
By Geography
Middle-East and Africa
Saudi Arabia (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Iran (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Egypt (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Oman (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
South Africa (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)
Self-monitoring Blood Glucose
By Component (Glucometer Device, Test strips, Lancets)
Continuous Glucose Monitoring
By Component (Sensors and Durables)

Report scope can be customized per your requirements. Click here.

主要市场趋势

试纸在中东和非洲血糖监测市场占有率最高

在中东和非洲血糖监测市场,试纸以1.36亿美元的收入占据45%的份额。价格通常是购买血糖试纸的一个重要问题。尽管各个国家都对规定的试纸提供报销,但大多数患者必须自掏腰包支付费用。在过去十年中,非洲的糖尿病患者人数正在增加。非洲与糖尿病相关的卫生总支出接近 95 亿美元,预计到 2045 年将翻一番。诸如金字塔基地项目等项目旨在提高人们对糖尿病的认识。在非洲的中低收入国家。​在中东和非洲,由于生活方式和饮食习惯,胰岛素使用者的血糖波动不时频繁,自我监测血糖的使用增加。​​​

Middle-East and Africa Blood Glucose Monitoring Market_trends

沙特阿拉伯和伊朗合计占中东和非洲血糖监测市场 50% 以上的份额

中东和非洲血糖监测市场的主要市场是沙特阿拉伯,占 36% 的市场份额,其次是伊朗和其他国家。沙特阿拉伯血糖监测设备的高销量是由于该国糖尿病患病率不断上升。中东国家的糖尿病患病率很高,如沙特阿拉伯 24%、科威特 23%、巴林 22%、卡塔尔 20% 和阿联酋 19%。价格通常是购买血糖监测设备的一个重要问题。尽管沙特阿拉伯、伊朗以及中东和非洲的其他国家等各个国家对规定的 SMBG 设备及其组件提供报销,但大多数患者必须自掏腰包。

Middle-East and Africa Blood Glucose Monitoring Market_Country

竞争格局

中东和非洲血糖监测市场高度分散,少数主要制造商拥有全球市场份额,而其余制造商则仅限于其他本地或特定区域的制造商,以及当地政府鼓励市场的举措。例如,2019 年 9 月,沙特阿拉伯卫生部与飞利浦 VitalHealth 和政府拥有的 Lean for Business Services 合作推出了人口健康管理。该计划将使卫生部能够筛查 500,000 名被诊断患有糖尿病和高血压的患者。

竞争格局

中东和非洲血糖监测市场高度分散,少数主要制造商拥有全球市场份额,而其余制造商则仅限于其他本地或特定区域的制造商,以及当地政府鼓励市场的举措。例如,2019 年 9 月,沙特阿拉伯卫生部与飞利浦 VitalHealth 和政府拥有的 Lean for Business Services 合作推出了人口健康管理。该计划将使卫生部能够筛查 500,000 名被诊断患有糖尿病和高血压的患者。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring Blood Glucose

      1. 5.1.1 By Component (Value and Volume, 2016 - 2026)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

    2. 5.2 Continuous Glucose Monitoring

      1. 5.2.1 By Component (Value and Volume, 2016 - 2026)

        1. 5.2.1.1 Sensors

        2. 5.2.1.2 Durables

    3. 5.3 By Geography

      1. 5.3.1 Middle-East and Africa

        1. 5.3.1.1 Saudi Arabia (Value and Volume, 2016 - 2026)

          1. 5.3.1.1.1 Self-monitoring Blood Glucose

            1. 5.3.1.1.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.1.2 Continuous Glucose Monitoring

            1. 5.3.1.1.2.1 By Component (Sensors and Durables)

        2. 5.3.1.2 Iran (Value and Volume, 2016 - 2026)

          1. 5.3.1.2.1 Self-monitoring Blood Glucose

            1. 5.3.1.2.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.2.2 Continuous Glucose Monitoring

            1. 5.3.1.2.2.1 By Component (Sensors and Durables)

        3. 5.3.1.3 Egypt (Value and Volume, 2016 - 2026)

          1. 5.3.1.3.1 Self-monitoring Blood Glucose

            1. 5.3.1.3.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.3.2 Continuous Glucose Monitoring

            1. 5.3.1.3.2.1 By Component (Sensors and Durables)

        4. 5.3.1.4 Oman (Value and Volume, 2016 - 2026)

          1. 5.3.1.4.1 Self-monitoring Blood Glucose

            1. 5.3.1.4.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.4.2 Continuous Glucose Monitoring

            1. 5.3.1.4.2.1 By Component (Sensors and Durables)

        5. 5.3.1.5 South Africa (Value and Volume, 2016 - 2026)

          1. 5.3.1.5.1 Self-monitoring Blood Glucose

            1. 5.3.1.5.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.5.2 Continuous Glucose Monitoring

            1. 5.3.1.5.2.1 By Component (Sensors and Durables)

        6. 5.3.1.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)

          1. 5.3.1.6.1 Self-monitoring Blood Glucose

            1. 5.3.1.6.1.1 By Component (Glucometer Device, Test strips, Lancets)

          2. 5.3.1.6.2 Continuous Glucose Monitoring

            1. 5.3.1.6.2.1 By Component (Sensors and Durables)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016 - 2026)

    2. 6.2 Type-2 Diabetes population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott

      2. 7.1.2 F. Hoffmann-La Roche AG

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Dexcom

      5. 7.1.5 Medtronics

      6. 7.1.6 Agamatrix Inc.

      7. 7.1.7 Bionime Corporation

      8. 7.1.8 Acon

      9. 7.1.9 Medisana

      10. 7.1.10 Trivida

      11. 7.1.11 I-SENS

      12. 7.1.12 Ascensia

      13. 7.1.13 Rossmax

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Middle-East and Africa Blood Glucose Monitoring Market market is studied from 2016 - 2027.

The Middle-East and Africa Blood Glucose Monitoring Market is growing at a CAGR of >11% over the next 5 years.

The Middle-East and Africa Blood Glucose Monitoring Market is valued at 340 Million USD in 2016.

The Middle-East and Africa Blood Glucose Monitoring Market is valued at 583 Million USD in 2027.

Medtronic, Dexcom, Johnson & Johnson, F. Hoffmann-La Roche AG, Abbott are the major companies operating in Middle-East and Africa Blood Glucose Monitoring Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!